Many plants produce compounds that serve as a defense against predators or pathogens. Some are also used by humans for a variety of beneficial purposes, such as in medicines. As recently as the early 1990s, a unique class of proteins previously unknown to science, the cyclotides, was discovered…
No Comments »
Filed under: Women's Health
A large observational study provides reassuring news on the safety of medications for attention-deficit hyperactivity disorder in middle-aged adults, researchers say. Medscape Medical News
No Comments »
Filed under: General Health News
The rate of violent childhood death is 5 times higher in the US than in Sweden or Western Australia, new research shows. Medscape Medical News
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — An FDA advisory panel punted on the question of approval for an inhaled version of the antipsychotic drug loxapine (Adasuve) to treat agitation in bipolar and schizophrenic patients, despite the risk for respiratory side effects.
No Comments »
Filed under: General Health News
(MedPage Today) — Infection control practices to prevent various hospital-acquired infections are being more frequently used, both at nonfederal and VA hospitals, researchers found.
No Comments »
Filed under: General Health News
(MedPage Today) — Case reports on the world’s smallest and third smallest newborns indicate that extremely low birth weight infants may never catch up in height or weight, but can develop normal motor and language skills.
No Comments »
Filed under: General Health News
(MedPage Today) — The incidence of colorectal cancer (CRC) among adults younger than 50 has increased by 2.1% in the past decade, according to results from a study of the National Cancer Database.
No Comments »
Filed under: General Health News
(MedPage Today) — A family-centered prevention and intervention program reduced behavioral and drug problems among black high school youths, a study in rural Georgia found.
No Comments »
Filed under: General Health News
Soligenix, Inc., a development stage biopharmaceutical company, announced the publication of results from its investigator-initiated Phase 2 “proof-of-concept” exploratory clinical trial of orBec for the prevention of acute Graft-versus-Host disease (GVHD) in patients undergoing myeloablative conditioning regimens with initiation of dosing prior to hematopoietic cell transplantation (HCT) and continuing through the post-transplantation period.
No Comments »
Filed under: Pharmacy News
A new treatment using leukemia patients’ own infection-fighting cells appears to protect them from infections and cancer recurrence following treatment with fludarabine-based chemotherapy, according to new research from the Perelman School of Medicine at the University of Pennsylvania.
No Comments »
Filed under: Pharmacy News
